UNITED
STATES

SECURITIES
AND EXCHANGE COMMISSION

Washington,
D.C. 20549



FORM
10-Q



|[X]  | QUARTERLY
    REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 
|---- | --------------------------------------------------------------------------------------------
|     | For
    the quarterly period ended June 30, 2020                                            
|     |                                                                                             
|[  ] | TRANSITION
    REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|     | For
    the transition period from ______________ to_______________                         



Commission
File No. 000-49654



CirTran
Corporation

(Exact
name of registrant as specified in its charter)



|Nevada                              |  | 68-0121636             
|----------------------------------- |  | -----------------------
|(State
    or other jurisdiction of |  | (IRS
    Employer      
|incorporation
    or organization)  |  | Identification
    No.)



6360
S Pecos Road, Suite 8, Las Vegas, NV 89120

(Address
of principal executive offices and zip code)



(801)
963-5112

(Registrant’s
telephone number, including area code)



Securities
registered pursuant to Section 12(b) of the Exchange Act:





|Title of each class |  | Trading Symbol(s) |  | Name of each exchange on which registered
|------------------- |  | ----------------- |  | -----------------------------------------
|None                |  | None              |  | None                                     





Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),
and (2) has been subject to such filing requirements for the past 90 days.

Yes
[X] No [  ]



Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant
to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that
the registrant was required to submit such files).

Yes
[X] No [  ]



Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,”
“smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.



| | Large
    accelerated filer [  ] | Accelerated
    filer [  ]       
| | -------------------------------- | ---------------------------------
| | Non-accelerated
    filer [X]    | Smaller
    reporting company [X]
| | Emerging
    growth company [  ] |                                  



If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]



Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes
[  ] No [X]



Indicate
the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date. As
of August 14, 2020, there were 4,500,417 shares of common stock, $0.001 par value, outstanding.


















CirTran
Corporation

Form
10-Q for the Three Months Ended June 30, 2020



TABLE
OF CONTENTS



|Item |                                                                                       | Page
|---- | ------------------------------------------------------------------------------------- | ----
|     | Part I—Financial Information                                                          |     
|     |                                                                                       |     
|1    | Financial Statements (Unaudited)                                                      | 3   
|     | Consolidated Balance Sheets                                                           | 3   
|     | Unaudited Consolidated Statements of Operations                                       | 4   
|     | Consolidated Statements of Stockholders’ Deficit                                      | 5   
|     | Unaudited Consolidated Statements of Cash Flows                                       | 6   
|     | Notes to the Financial Statements                                                     | 7   
|2    | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 17  
|3    | Quantitative and Qualitative Disclosures about Market Risk                            | 19  
|4    | Controls and Procedures                                                               | 20  
|     |                                                                                       |     
|     | Part II—Other Information                                                             |     
|     |                                                                                       |     
|6    | Exhibits                                                                              | 20  
|     | Signatures                                                                            | 21  



2







PART
I–FINANCIAL INFORMATION



ITEM
1. FINANCIAL STATEMENTS



CIRTRAN
CORPORATION

CONSOLIDATED
BALANCE SHEETS



|                                                                                                                                                                          |  | June 30, 2020 |             |   | December 31, 2019 |  
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |  | ------------- | ----------- | - | ----------------- | -
|                                                                                                                                                                          |  | (unaudited)   |             |   |                   |  
|ASSETS                                                                                                                                                                    |  |               |             |   |                   |  
|                                                                                                                                                                          |  |               |             |   |                   |  
|Current assets                                                                                                                                                            |  |               |             |   |                   |  
|Cash                                                                                                                                                                      |  | $             | 102,331     |   |                   | $
|Inventory                                                                                                                                                                 |  |               | 190,170     |   |                   |  
|Deposits on inventory                                                                                                                                                     |  |               | 40,845      |   |                   |  
|Deposits on inventory - related party                                                                                                                                     |  |               | 185,375     |   |                   |  
|Other current assets                                                                                                                                                      |  |               | 8,706       |   |                   |  
|Assets from discontinued operations                                                                                                                                       |  |               | -           |   |                   |  
|Total current assets                                                                                                                                                      |  |               | 527,427     |   |                   |  
|                                                                                                                                                                          |  |               |             |   |                   |  
|Investment in securities at cost                                                                                                                                          |  |               | 300,000     |   |                   |  
|Property and equipment, net of accumulated depreciation                                                                                                                   |  |               | -           |   |                   |  
|                                                                                                                                                                          |  |               |             |   |                   |  
|Total assets                                                                                                                                                              |  | $             | 827,427     |   |                   | $
|                                                                                                                                                                          |  |               |             |   |                   |  
|LIABILITIES AND STOCKHOLDERS’ DEFICIT                                                                                                                                     |  |               |             |   |                   |  
|                                                                                                                                                                          |  |               |             |   |                   |  
|Current liabilities                                                                                                                                                       |  |               |             |   |                   |  
|Bank overdraft                                                                                                                                                            |  | $             | -           |   |                   | $
|Accounts payable                                                                                                                                                          |  |               | 2,127,106   |   |                   |  
|Related-party payable                                                                                                                                                     |  |               | 13,740      |   |                   |  
|Short-term advances payable                                                                                                                                               |  |               | 139,904     |   |                   |  
|Short-term advances payable - related parties                                                                                                                             |  |               | 492,035     |   |                   |  
|Accrued liabilities                                                                                                                                                       |  |               | 1,285,294   |   |                   |  
|Accrued payroll and compensation expense                                                                                                                                  |  |               | 3,939,906   |   |                   |  
|Accrued interest, current portion                                                                                                                                         |  |               | 2,597,911   |   |                   |  
|Convertible debenture, current portion, net of discounts                                                                                                                  |  |               | 264,284     |   |                   |  
|Note payable, current portion                                                                                                                                             |  |               | 90,000      |   |                   |  
|Note payable to stockholders and members                                                                                                                                  |  |               | 151,833     |   |                   |  
|Derivative liability                                                                                                                                                      |  |               | 1,258,096   |   |                   |  
|Liabilities from discontinued operations                                                                                                                                  |  |               | 26,425,376  |   |                   |  
|Total current liabilities                                                                                                                                                 |  |               | 38,785,485  |   |                   |  
|                                                                                                                                                                          |  |               |             |   |                   |  
|Accrued interest, net of current portion                                                                                                                                  |  |               | 1,430,696   |   |                   |  
|Note payable, net of current portion                                                                                                                                      |  |               | 656,000     |   |                   |  
|Convertible debenture, net of current portion, net of discount                                                                                                            |  |               | 1,733,623   |   |                   |  
|Total liabilities                                                                                                                                                         |  |               | 42,433,304  |   |                   |  
|                                                                                                                                                                          |  |               |             |   |                   |  
|Commitments and contingencies                                                                                                                                             |  |               | -           |   |                   |  
|                                                                                                                                                                          |  |               |             |   |                   |  
|Stockholders’ deficit                                                                                                                                                     |  |               |             |   |                   |  
|Common stock, par value $0.001; 100,000,000 shares authorized; 4,500,417 and 4,500,417 shares issued and outstanding at June 30, 2020 and December 31, 2019, respectively |  |               | 4,500       |   |                   |  
|Additional paid-in capital                                                                                                                                                |  |               | 37,222,671  |   |                   |  
|Accumulated deficit                                                                                                                                                       |  |               | (79,005,548 | ) |                   |  
|Total stockholders’ deficit                                                                                                                                               |  |               | (41,778,377 | ) |                   |  
|                                                                                                                                                                          |  |               |             |   |                   |  
|Total liabilities and stockholders’ deficit                                                                                                                               |  | $             | 827,427     |   |                   | $



The
accompanying notes are an integral part of these unaudited consolidated financial statements.



3







CIRTRAN
CORPORATION

UNAUDITED
CONSOLIDATED STATEMENTS OF OPERATIONS



|                                                                          |  | Three Months Ended June 30, |           |   | Six Months Ended June 30, |  
|------------------------------------------------------------------------- |  | --------------------------- | --------- | - | ------------------------- | -
|                                                                          |  | 2020                        |           |   | 2019                      |  
|Net sales                                                                 |  | $                           | 528,232   |   |                           | $
|Cost of sales                                                             |  |                             | 195,838   |   |                           |  
|Gross profit                                                              |  |                             | 332,394   |   |                           |  
|                                                                          |  |                             |           |   |                           |  
|Operating expenses                                                        |  |                             |           |   |                           |  
|Selling, general and administrative expenses                              |  |                             | 78,884    |   |                           |  
|Total operating expenses                                                  |  |                             | 78,884    |   |                           |  
|                                                                          |  |                             |           |   |                           |  
|Income (loss) from operations                                             |  |                             | 253,510   |   |                           |  
|                                                                          |  |                             |           |   |                           |  
|Other income (expense)                                                    |  |                             |           |   |                           |  
|Interest expense                                                          |  |                             | (156,568  | ) |                           |  
|Loss on disposal of equipment                                             |  |                             | -         |   |                           |  
|Loss on derivative valuation                                              |  |                             | (289,050  | ) |                           |  
|Other income                                                              |  |                             | 2,000     |   |                           |  
|Total other income (expense)                                              |  |                             | (443,618  | ) |                           |  
|                                                                          |  |                             |           |   |                           |  
|Net loss from continuing operations                                       |  |                             | (190,108  | ) |                           |  
|                                                                          |  |                             |           |   |                           |  
|Loss from discontinued operations                                         |  |                             | (38,262   | ) |                           |  
|                                                                          |  |                             |           |   |                           |  
|Net loss                                                                  |  | $                           | (228,370  | ) |                           | $
|                                                                          |  |                             |           |   |                           |  
|Net loss from continuing operations per common share, basic and diluted   |  | $                           | (0.04     | ) |                           | $
|Net loss from discontinued operations per common share, basic and diluted |  | $                           | (0.01     | ) |                           | $
|Net loss per common share, basic and diluted                              |  | $                           | (0.05     | ) |                           | $
|Basic and diluted weighted average common shares outstanding              |  |                             | 4,500,417 |   |                           |  



The
accompanying notes are an integral part of these unaudited consolidated financial statements.



4







CIRTRAN
CORPORATION

CONSOLIDATED
STATEMENTS OF STOCKHOLDERS’ DEFICIT

FOR
THE THREE AND SIX MONTHS ENDED JUNE 30, 2019 (REVISED)



|                                                |  | Common
    Stock |           |  | Additional
    Paid-in |   |       | Accumulated |  |   |            | 
|----------------------------------------------- |  | ---------------- | --------- |  | ---------------------- | - | ----- | ----------- |  | - | ---------- | 
|                                                |  | Shares           |           |  | Amount                 |   |       | Capital     |  |   | Deficit    | 
|Balance,
    December 31, 2018                  |  |                  | 4,500,417 |  |                        | $ | 4,500 |             |  | $ | 37,222,615 | 
|Net
    loss, three months ended March 31, 2019 |  |                  | -         |  |                        |   | -     |             |  |   | -          | 
|Balance,
    March 31, 2019                     |  |                  | 4,500,417 |  |                        |   | 4,500 |             |  |   | 37,222,615 | 
|Net
    loss, three months ended June 30, 2019  |  |                  | -         |  |                        |   | -     |             |  |   | -          | 
|Balance,
    June 30, 2019                      |  |                  | 4,500,417 |  |                        | $ | 4,500 |             |  | $ | 37,222,615 | 





CIRTRAN
CORPORATION

CONSOLIDATED
STATEMENTS OF STOCKHOLDERS’ DEFICIT

FOR
THE THREE AND SIX MONTHS ENDED JUNE 30, 2020



|                                                |  | Common
    Stock |           |  | Additional
    Paid-in |   |       | Accumulated |  |   |            | 
|----------------------------------------------- |  | ---------------- | --------- |  | ---------------------- | - | ----- | ----------- |  | - | ---------- | 
|                                                |  | Shares           |           |  | Amount                 |   |       | Capital     |  |   | Deficit    | 
|Balance,
    December 31, 2019                  |  |                  | 4,500,417 |  |                        | $ | 4,500 |             |  | $ | 37,222,615 | 
|Stock
    option expense                        |  |                  | -         |  |                        |   | -     |             |  |   | 56         | 
|Net
    loss, three months ended March 31, 2020 |  |                  | -         |  |                        |   | -     |             |  |   | -          | 
|Balance,
    March 31, 2020                     |  |                  | 4,500,417 |  |                        |   | 4,500 |             |  |   | 37,222,671 | 
|Net
    loss, three months ended June 30, 2020  |  |                  | -         |  |                        |   | -     |             |  |   | -          | 
|Balance,
    June 30, 2020                      |  |                  | 4,500,417 |  |                        | $ | 4,500 |             |  | $ | 37,222,671 | 





The
accompanying notes are an integral part of these unaudited consolidated financial statements.



5







CIRTRAN
CORPORATION

UNAUDITED
CONSOLIDATED STATEMENTS OF CASH FLOWS



|                                                                           |  | Six Months Ended June 30, |         
|-------------------------------------------------------------------------- |  | ------------------------- | --------
|                                                                           |  | 2020                      |         
|Cash flows from operating activities                                       |  |                           |         
|Net loss from continuing operations                                        |  | $                         | (467,219
|Adjustments to reconcile net loss to net cash used in operating activities |  |                           |         
|Depreciation expense                                                       |  |                           | -       
|Loss on derivative valuation                                               |  |                           | 358,264 
|Debt discount amortization                                                 |  |                           | 61,018  
|Loss on disposal of equipment                                              |  |                           | 9,771   
|Stock option expense                                                       |  |                           | 56      
|Expenses paid on behalf of Company by a related party                      |  |                           | 1,940   
|Changes in operating assets and liabilities:                               |  |                           |         
|Inventory                                                                  |  |                           | (171,356
|Deposits on inventory                                                      |  |                           | (40,845 
|Deposits on inventory - related party                                      |  |                           | (185,375
|Other current assets                                                       |  |                           | (7,496  
|Accounts payable                                                           |  |                           | 5,706   
|Accrued liabilities                                                        |  |                           | 207,295 
|Accrued payroll and compensation                                           |  |                           | 182,270 
|Accrued interest                                                           |  |                           | 251,563 
|Net cash provided by (used in) continuing operating activities             |  |                           | 205,592 
|Net cash used in discontinued operations                                   |  |                           | -       
|Net cash provided by (used in) operating activities                        |  |                           | 205,592 
|                                                                           |  |                           |         
|Cash flows from financing activities                                       |  |                           |         
|Proceeds from bank overdraft                                               |  |                           | (1,611  
|Proceeds from convertible loans payable                                    |  |                           | 15,000  
|Proceeds from related-party loans                                          |  |                           | 10,700  
|Repayments of related-party loans                                          |  |                           | (262,350
|Proceeds from loans payable                                                |  |                           | 156,000 
|Repayments of loans payable                                                |  |                           | (21,000 
|Cash provided by (used in) financing activities                            |  |                           | (103,261
|Cash used in discontinued financing activities                             |  |                           | -       
|Net cash provided by (used in) financing activities                        |  |                           | (103,261
|                                                                           |  |                           |         
|Net change in cash                                                         |  |                           | 102,331 
|Cash, beginning of period                                                  |  |                           | -       
|Cash, end of period                                                        |  | $                         | 102,331 
|                                                                           |  |                           |         
|Supplemental disclosure of cash flow information                           |  |                           |         
|Cash paid for interest                                                     |  | $                         | -       
|Cash paid for income taxes                                                 |  | $                         | -       
|                                                                           |  |                           |         
|Supplemental disclosure of noncash investing activities                    |  |                           |         
|Initial measurement of derivative liability                                |  | $                         | 5,753   



The
accompanying notes are an integral part of these unaudited consolidated financial statements.



6







CIRTRAN
CORPORATION

NOTES
TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

JUNE
30, 2020



NOTE
1—BASIS OF PRESENTATION



The
consolidated financial statements of CirTran Corporation for the three- and six-month periods ended June 30, 2020 and 2019, are
not audited. Our consolidated financial statements are prepared in accordance with the requirements for unaudited interim periods
and, consequently, do not include all disclosures required to be made in conformity with accounting principles generally accepted
in the United States of America. In the opinion of our management, the accompanying consolidated financial statements contain
all adjustments, consisting of normal recurring accruals, necessary for a fair presentation of our financial position as of June
30, 2020, and December 31, 2019, and our results of operations and cash flows for the periods ended June 30, 2020 and 2019. The
results of operations for the three and six months ended June 30, 2020 and 2019, are not necessarily indicative of the results
for a full-year period. These interim consolidated financial statements should be read in conjunction with the financial statements
included in our annual report on Form 10-K for the year ended December 31, 2019.



NOTE
2—SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES



Principles
of Consolidation



We
consolidate all of our majority-owned subsidiaries, companies over which we exercise control through majority voting rights, and
companies in which we have a variable interest and we are the primary beneficiary. We account for our investments in common stock
of other companies that we do not control, but over which we can exert significant influence using the cost method.



The
consolidated financial statements as of and for the periods ended June 30, 2020, include the accounts of CirTran Corporation and
our wholly owned subsidiaries: CirTran Products Corp., LBC Products, Inc., and CirTran - Asia, Inc. All intercompany balances
and transactions have been eliminated.



The
consolidated financial statements as of and for the periods ended June 30, 2019, include the accounts of CirTran Corporation and
our wholly owned subsidiaries: CirTran Products Corp., CirTran Corporation (Utah), CirTran Beverage Corp., CirTran Online Corp.,
CirTran Media Corp., Racore Network, and CirTran - Asia, Inc. All intercompany balances and transactions have been eliminated.



Use
of Estimates



In
preparing the financial statements in accordance with accounting principles generally accepted in the United States of America,
management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure
of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses
during the reported periods. Actual results could differ from those estimates.



Revenue
Recognition



We
follow Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 606, Revenue
from Contracts with Customers, for revenue recognition. Adoption of ASC 606 did not have a significant impact on our financial
statements. We generate revenue by providing product design services and through the sales of tangible product. We recognize revenue
upon transfer of control of promised products or services to customers in an amount that reflects the consideration expected to
be received in exchange for those products or services. We determine the transaction price associated with each deliverable based
on the unique contract with the customer, typically a purchase order received that we have accepted the terms of. Revenue is recognized
net of allowances for returns and any taxes collected from customers, which are subsequently remitted to governmental authorities.



Cash
and Cash Equivalents



We
consider all highly liquid, short-term investments with an original maturity of three months or less to be cash equivalents. We
did not hold any cash equivalents as of June 30, 2020, or December 31, 2019.



7







Leases



In
February 2016, the FASB issued ASU 2016-02, Leases (Topic 842),which superseded guidance in ASC 840, Leases,which
we adopted for the year ended December 31, 2019 under the modified retrospective transition approach by applying the new standard
to all leases existing at the date of initial application. We account for short term leases, those lasting fewer than 12 months,
using the practical expedient as outlined in the guidance, which does not include recording such leases on the balance sheet.



Investment
in Securities



Our
cost-method investment consists of an investment in a private digital multi-media technology company that totaled $300,000 at
June 30, 2020, and December 31, 2019. As we owned less than 20% of that company’s stock as of each date, and no significant
influence or control exists, the investment is accounted for using the cost method. We evaluated the investment for impairment
and determined there was none during the periods presented.



Property
and Equipment



We
incur certain costs associated with the design and development of molds and dies for our contract-manufacturing segment. These
costs are held as deposits on the balance sheet until the molds or dies are finished and ready for use. At that point, the costs
are included as part of production equipment in property and equipment and are amortized over their useful lives. We hold title
to all molds and dies used in the manufacture of products. The capitalized cost, net of accumulated depreciation, associated with
molds and dies included in property and equipment at June 30, 2020, and December 31, 2019, was $0 and $9,772, respectively. All
property and equipment that was in service during the year ended December 31, 2019 was disposed of during the current period.



Depreciation
expense is recognized in amounts equal to the cost of depreciable assets over estimated service lives. Leasehold improvements
are amortized over the shorter of the life of the lease or the service life of the improvements. The straight-line method of depreciation
and amortization is followed for financial reporting purposes. Maintenance, repairs, and renewals that neither materially add
to the value of the property nor appreciably prolong its life are charged to expense as incurred. Gains or losses on dispositions
of property and equipment are included in operating results.



Impairment
of Long-Lived Assets



We
review our long-lived assets, including intangibles, for impairment when events or changes in circumstances indicate that the
carrying value of an asset may not be recoverable. At each balance sheet date, we evaluate whether events and circumstances have
occurred that indicate possible impairment. We use an estimate of future undiscounted net cash flows from the related asset or
group of assets over their remaining life in measuring whether the assets are recoverable. We did not record expenses for the
impairment of long-lived assets during the periods ended June 30, 2020 or 2019.



Financial
Instruments with Derivative Features



We
do not hold or issue derivative instruments for trading purposes. However, we have financial instruments that are considered derivatives
or contain embedded features subject to derivative accounting. Embedded derivatives are valued separately from the host instrument
and are recognized as derivative liabilities in our balance sheet. We measure these instruments at their estimated fair value
and recognize changes in their estimated fair value in results of operations during the period of change. We have estimated the
fair value of these embedded derivatives using a Multinomial Lattice model. The fair values of the derivative instruments are
measured each reporting period.



Inventories



Inventories
are stated at the lower of average cost or market value. Cost on manufactured inventories includes labor, material, and overhead.
Overhead cost is based on indirect costs allocated to cost of sales, work-in-process inventory, and finished goods inventory.
Indirect overhead costs have been charged to cost of sales or capitalized as inventory, based on management’s estimate of
the benefit of indirect manufacturing costs to the manufacturing process. Inventories consist of finished goods as we do not carry
raw materials for manufacturing products.



8







When
there is evidence that the inventory’s value is less than original cost, the inventory is reduced to market value. We determine
market value on current resale amounts and whether technological obsolescence exists. We will seek agreements with manufacturing
customers that require them to purchase their inventory items in the event they cancel their business with us.



From
time to time, we will place deposits on inventory to be delivered in the future. These deposits are carried as a separate balance
sheet component and totaled $40,845 (non-related party) and $185,375 (related party) as of June 30, 2020. There were no deposits
on inventory as of December 31, 2019.



Inventory
balances consisted of the following:



|               |  | June 30, 2020 |         |  | December 31, 2019 |  
|-------------- |  | ------------- | ------- |  | ----------------- | -
|Finished goods |  | $             | 99,638  |  |                   |  
|Raw materials  |  |               | 90,532  |  |                   |  
|Total          |  | $             | 190,170 |  |                   | $



Stock-Based
Compensation



We
have outstanding stock options to directors and employees, which are described more fully in Note 12 – Stock Options
and Warrants. We account for our stock options in accordance with ASC 718-10, Accounting for Stock Issued to Employees,
and ASU 2018-07, Improvements to Nonemployee Share-Based Payment Accounting, as updated, which requires the recognition
of the cost of employee services received in exchanged for an award of equity instruments in the financial statements and is measured
based on the grant date fair value of the award. ASC 718-10 also requires the stock option compensation expense to be recognized
over the period during which an employee is required to provide service in exchange for the award (typically the vesting period).
There was no impact to our methodology for accounting for equity based compensation as a result of adopting ASC 718-10 and ASU
2018-07.



Stock-based
employee compensation was $56 and $600 for the six months ended June 30, 2020 and 2019, respectively.



Fair
Value of Financial Instruments



The
carrying amounts reported in the accompanying consolidated financial statements for cash, notes payable, and accounts payable
approximate fair value because of the immediate or short-term maturities of these financial instruments.



ASC
820-10-15, Fair Value Measurement-Overall-Scope and Scope Exceptions, defines fair value, thereby eliminating inconsistencies
in guidance found in various prior accounting pronouncements, and increases disclosures surrounding fair value calculations. ASC
820-10-15 establishes a three-tiered fair value hierarchy that prioritizes inputs to valuation techniques used in fair value calculations.
The three levels of inputs are defined as follows:



| | Level
    1—Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets
    or liabilities.                                                                                                                                                                                                                                                                                                                                                                                                 
| | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
| | Level
    2—Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for
    the asset or liability, such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical
    assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived
    valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market
    data.
| |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
| | Level
    3—Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that
    are significant to the measurement of the fair value of the assets or liabilities.                                                                                                                                                                                                                                                                                                                             



Accounts
payable and related-party payables have fair values that approximate the carrying value due to the short-term nature of these
instruments. Derivative liabilities are measured using level 3 inputs.



9







|                       |  | Total Fair Value at June 30, 2020 |           |  | Quoted prices in active markets (Level 1) |   |   | Significant other observable inputs (Level 2) |  |   | Significant unobservable inputs (Level 3) | 
|---------------------- |  | --------------------------------- | --------- |  | ----------------------------------------- | - | - | --------------------------------------------- |  | - | ----------------------------------------- | 
|Derivative liabilities |  | $                                 | 1,258,096 |  |                                           | $ | - |                                               |  | $ | -                                         | 



|                       |  | Total Fair Value at December 31, 2019 |         |  | Quoted prices in active markets (Level 1) |   |   | Significant other observable inputs (Level 2) |  |   | Significant unobservable inputs (Level 3) | 
|---------------------- |  | ------------------------------------- | ------- |  | ----------------------------------------- | - | - | --------------------------------------------- |  | - | ----------------------------------------- | 
|Derivative liabilities |  | $                                     | 894,079 |  |                                           | $ | - |                                               |  | $ | -                                         | 



Loss
per Share



Basic
loss per share (EPS) is calculated by dividing net loss available to common shareholders by the weighted-average number of common
shares outstanding during each period. Diluted EPS is similarly calculated, except that the weighted-average number of common
shares outstanding would include common shares that may be issued subject to existing rights with dilutive potential when applicable.
There were 196,726,286 potentially issuable shares from the conversions of convertible debentures outstanding that were excluded
in dilutive outstanding shares for the three and six months ended June 30, 2020, due to the anti-dilutive effect these would have
on net loss per share. There were no such shares issuable as of June 30, 2019. We do not currently have adequate authorized but
unissued shares to satisfy our obligations should all instruments eligible to convert to common stock be exercised. We are not
currently contemplating an increase in our authorized shares but may do so in the future.



Short-term
Advances



We
have short-term advances with various individuals. These advances are due upon demand, carry no interest, and are not collateralized.
These advances are classified as short-term liabilities.



Recently
Issued Accounting Pronouncements



In
August 2020, the FASB issued ASU 2020-06 “Debt with Conversion and Other Options”which will be effective for
fiscal years beginning after December 15, 2021. We are evaluating the impacts this new pronouncement will have on our financial
statements.



NOTE
3—GOING CONCERN AND REALIZATION OF ASSETS



In
October 2016, we lost our ability to continue energy drink distribution, our principal source of revenue, after receiving an unfavorable
ruling in our suit against Playboy Enterprises, Inc.



The
accompanying unaudited consolidated financial statements have been prepared in conformity with accounting principles generally
accepted in the United States of America, which contemplate our continuation as a going concern. We had a working capital deficiency
of $38,085,558 and $37,994,597 as of June 30, 2020, and December 31, 2019, respectively, and a net loss from continuing operations
of $294,719 and $430,758 during the six months ended June 30, 2020 and 2019, respectively. As of June 30, 2020, and December 31,
2019, we had an accumulated deficit of $78,833,048 and $78,461,806, respectively. These conditions raise substantial doubt about
our ability to continue as a going concern.



Our
ability to continue as a going concern is dependent upon our ability to successfully accomplish our business plan described in
the following paragraphs and eventually attain profitable operations. The accompanying financial statements do not include any
adjustments that may be necessary if we are unable to continue as a going concern.



In
the coming year, our foreseeable cash requirements will relate to development of business operations and associated expenses.
We may experience a cash shortfall and be required to raise additional capital.



10







Historically,
we have mostly relied upon shareholder loans and advances to finance operations and growth. Management may raise additional capital
by retaining net earnings, if any, or through future public or private offerings of our stock or loans from private investors,
although we cannot assure that we will be able to obtain such financing. Our failure to do so could have a material and adverse
effect upon us and our shareholders.



NOTE
4—PROPERTY AND EQUIPMENT



Property
and equipment and estimated service lives consist of the following:



|                               |  | June 30, 2020 |   |  | December 31, 2019 |   |            | Useful Life (years)
|------------------------------ |  | ------------- | - |  | ----------------- | - | ---------- | -------------------
|Furniture and office equipment |  | $             | - |  |                   | $ | 177,900    |                    
|Leasehold improvements         |  |               | - |  |                   |   | 997,714    |                    
|Production equipment           |  |               | - |  |                   |   | 2,886,267  |                    
|Vehicles                       |  |               | - |  |                   |   | 53,209     |                    
|Total                          |  |               | - |  |                   |   | 4,115,090  |                    
|Less: accumulated depreciation |  |               | - |  |                   |   | (4,105,318 | )                  
|Property and equipment, net    |  | $             | - |  |                   | $ | 9,772      |                    



During
the six months ended June 30, 2020, we disposed of all of our remaining assets as part of our adoption of our new agreement to
develop and distribute certain products. There was no consideration received upon disposal resulting in a net loss equal to the
net book value of $9,771 during the six months ended June 30, 2020. We recorded $0 and $573 of depreciation expense during the
three months ended June 30, 2020 and 2019, respectively. We recorded $0 and $1,146 of depreciation expense during the six months
ended June 30, 2020 and 2019, respectively.



NOTE
5—RELATED-PARTY TRANSACTIONS



Transactions
Involving Officers, Directors, and Stockholders



In
2007, we issued a 10% promissory note to a family member of our president in exchange for $300,000. The note was due on demand
after May 2008. There were no repayments made during the periods presented. At June 30, 2020, and December 31, 2019, the principal
amount owing on the note was $151,833 and $151,833, respectively.



On
March 31, 2008, we issued to this same family member, along with two other company shareholders, promissory notes totaling $315,000
($105,000 each). Under the terms of these three $105,000 notes, we received total proceeds of $300,000 and agreed to repay the
amount received plus a 5% borrowing fee. The notes were due April 30, 2008, after which they were due on demand, with interest
accruing at 12% per annum. We made no payments towards the outstanding notes during the periods presented. The principal balance
owing on the notes as of June 30, 2020, and December 31, 2019, totaled $72,466 and $72,466, respectively.



During
the six months ended June 30, 2020, we made repayments to related parties of $262,350 and advances of $10,700 were received from
related parties. Additionally, related parties paid expenses totaling $1,940 directly to vendors on our behalf. There were $492,035
and $738,655 of short-term advances due to related parties as of June 30, 2020, and December 31, 2019, respectively. The advances
are due on demand and as such included in current liabilities.



We
have agreed to issue stock options to Iehab Hawatmeh, our president, as compensation for services provided as our chief executive
officer. The terms of this employment agreement require us to grant options to purchase 6,000 shares of our stock each year, with
an exercise price equal to the fair market price of our common stock as of the grant date. During the six months ended June 30,
2020, we granted options to purchase 6,000 shares of common stock relating to this employee agreement. There were also options
to purchase 6,000 shares of common stock that expired during the six months ended June 30, 2020. There was 30,000 and 30,000 outstanding
stock options held by Iehab Hawatmeh as of June 30, 2020, and December 31, 2019, respectively. See Note 6 – Other Accrued
Liabilities and Note 12 – Stock Options and Warrants.



11







As
of June 30, 2020, and December 31, 2019, we owed our president a total of $900,339 and $903,740 in unsecured advances. The advances
and short-term bridge loans were approved by our board of directors under a 5% borrowing fee. The borrowing fees were waived by
our president on these loans. These amounts are included in our liabilities from discontinued operations.



As
of June 30, 2020 and December 31, 2019, we owed a total of $13,740 to a related party through trade payables incurred in the normal
course of business. These amounts are shown as a separate related party payable on the balance sheet as of each reporting date.



During
the six months ended June 30, 2020, we made deposits with a related party inventory supplier totaling $185,375. The related party
is an entity controlled by our CEO and all transactions were at arm’s length with the amounts paid for inventory at a 2%
markup over the related party’s cost. Total inventory purchases from the related party were $75,091 during the six months
ended June 30, 2020.



NOTE
6—OTHER ACCRUED LIABILITIES



Accrued
tax liabilities consist of delinquent payroll taxes, interest, and penalties owed by us to the Internal Revenue Service (“IRS”)
and other tax entities.



Accrued
liabilities consist of the following:



|                |  | June 30, 2020 |           |  | December 31, 2019 |  
|--------------- |  | ------------- | --------- |  | ----------------- | -
|                |  |               |           |  |                   |  
|Tax liabilities |  | $             | 804,084   |  |                   | $
|Other           |  |               | 481,210   |  |                   |  
|Total           |  | $             | 1,285,294 |  |                   | $



Other
accrued liabilities as of June 30, 2020, and December 31, 2019, include a non-interest-bearing payable totaling $45,000 that is
due on demand.



Accrued
payroll and compensation liabilities consist of the following:



|                       |  | June 30, 2020 |           |  | December 31, 2019 |  
|---------------------- |  | ------------- | --------- |  | ----------------- | -
|                       |  |               |           |  |                   |  
|Stock option expenses  |  | $             | -         |  |                   | $
|Director fees          |  |               | 135,000   |  |                   |  
|Bonus expenses         |  |               | 126,858   |  |                   |  
|Commissions            |  |               | 2,148     |  |                   |  
|Administrative payroll |  |               | 3,675,900 |  |                   |  
|Total                  |  | $             | 3,939,906 |  |                   | $



Stock
option expenses consist of employee stock option expenses. During the six months ended June 30, 2020, we resumed accruing wages
for our CEO which are included in administrative payroll. A total of $172,500 was accrued during the six months ended June 30,
2020 which are included in cost of sales as a direct labor cost of fulfilling performance obligations related to our revenue recognized.



NOTE
7—COMMITMENTS AND CONTINGENCIES



Litigation
and Claims



Various
vendors, service providers, and others have asserted legal claims in previous years. These creditors generally are not actively
seeking collection of amounts due them, and we have determined that the probability of realizing any loss on these claims is remote
and will seek to compromise and settle at a deep discount any of such claims that are asserted for collection. These amounts are
included in our current liabilities. We have not accrued any liability for claims or judgments that we have determined to be barred
by the applicable statute of limitations, which generally is eight years for judgments in Utah.



12







Playboy
Enterprises, Inc.



Our
affiliate, Play Beverages, LLC, filed suit against Playboy Enterprises, Inc., in Cook County, Illinois, Circuit Court in October
2012 asserting numerous claims, including breach of contract and tortious interference. Playboy responded with a counterclaim
of breach of contract and trademark infringement. After proceedings in October 2016, the court awarded a judgment to Playboy of
$6.6 million against Play Beverages and CirTran Beverage Corp., our subsidiary. The court denied our motion for a new trial and
awarded Playboy treble patent infringement damages and attorney’s fees. We filed a notice of appeal in July 2017 and again
in March 2018. Playboy has initiated collection efforts but has recovered no funds. In September 2018, the appellate court affirmed
the judgment of the circuit court. We have accrued $17,205,599 as of June 30, 2020, and December 31, 2019, related to this judgment,
which is included in liabilities in discontinued operations.



Delinquent
Payroll Taxes, Interest, and Penalties



In
November 2004, the IRS accepted our amended offer in compromise (the “Offer”) to settle delinquent payroll taxes,
interest, and penalties, which requires us to pay $500,000, remain current in our payment of taxes for five years, and forego
claiming any net operating losses for the years 2001 through 2015 or until we pay taxes on future profits in an amount equal to
the taxes of $1,455,767 waived by the Offer. In June 2013, we entered into a partial installment agreement to pay $768,526 in
unpaid 2009 payroll taxes, which requires us to pay the IRS 5% of cash deposits. The monthly payments are to continue until the
account balances are paid in full or until the collection statute of limitation expires on October 6, 2020. There was $1,048,756
and $1,048,756 due as of June 30, 2020, and December 31, 2019, respectively.



Employment
Agreements



We
engage Iehab Hawatmeh, our president and chief executive officer, through an employment agreement entered in August 2009 and amended
in September 2017. In July 2017, Mr. Hawatmeh had resigned all positions with us to pursue other business activities, thereby
effectively terminating the agreement. However, the amendment to his employment agreement in September 2017 reinstated Mr. Hawatmeh
to his previous positions, with a salary in an amount to be determined. Among other things, the reinstated employment agreement:
(a) grants options to purchase a minimum of 6,000 shares of our stock each year, with an exercise price equal to the market price
of our common stock as of the grant date, for the maximum term allowed under our stock option plan; (b) provides for health insurance
coverage, cell phone, car allowance, life insurance, and director and officer liability insurance, as well as any other bonus
approved by our board; and (c) includes additional incentive compensation as follows: (i) a quarterly bonus equal to 5% of our
earnings before interest, taxes, depreciation and amortization for the applicable quarter; (ii) bonuses equal to 1% of the net
purchase price of any acquisitions we complete that are directly generated and arranged by Mr. Hawatmeh; and (iii) an annual bonus
(payable quarterly) equal to 1% of our gross sales of all products, net of returns and allowances. On January 1, 2020, we resumed
accruing wages for our CEO. A total of $172,500 was accrued during the six months ended June 30, 2020.



We
also have an oral agreement with our other director that requires us to issue options to purchase 2,000 shares of our common stock
each year.



During
the six months ended June 30, 2020 and 2019, we granted options to purchase 8,000 and 6,000 shares of common stock to Mr. Hawatmeh
and Ms. Hollinger, respectively. We recorded expenses totaling $56 and $600 during the six months ended June 30, 2020 and 2019,
respectively, for these options.



We
have no other agreements requiring the grant of options.



NOTE
8—NOTES PAYABLE



Notes
payable consisted of the following:



|                                                                               |  | June 30, 2020 |         |  | December 31, 2019 |  
|------------------------------------------------------------------------------ |  | ------------- | ------- |  | ----------------- | -
|                                                                               |  |               |         |  |                   |  
|Note payable to former service provider for past due account payable (current) |  | $             | 90,000  |  |                   | $
|Note payable for settlement of debt (long term)                                |  |               | 500,000 |  |                   |  
|Small Business Administration loan                                             |  |               | 156,000 |  |                   |  
|Total                                                                          |  | $             | 746,000 |  |                   | $



There
was $181,220 and $157,535 of accrued interest due on these note as of June 30, 2020, and December 31, 2019, respectively.



13







NOTE
9—CONVERTIBLE DEBENTURES



Convertible
debentures consisted of the following:



|                                                                                                       |  | June 30, 2020 |           |   | December 31, 2019 |  
|------------------------------------------------------------------------------------------------------ |  | ------------- | --------- | - | ----------------- | -
|                                                                                                       |  |               |           |   |                   |  
|Convertible debenture, 5% stated interest rate, secured by all of our assets, due on November 12, 2020 |  | $             | 200,000   |   |                   | $
|Convertible debenture, 5% stated interest rate, secured by all of our assets, due on November 30, 2020 |  |               | 25,000    |   |                   |  
|Convertible debenture, 5% stated interest rate, secured by all of our assets, due on February 8, 2021  |  |               | 25,000    |   |                   |  
|Convertible debenture, 5% stated interest rate, secured by all of our assets, due on December 23, 2020 |  |               | 25,000    |   |                   |  
|Convertible debenture, 5% stated interest rate, secured by all of our assets, due on April 30, 2027    |  |               | 2,390,528 |   |                   |  
|Subtotal                                                                                               |  | $             | 2,665,528 |   |                   | $
|Less: discounts                                                                                        |  |               | (667,621  | ) |                   |  
|Total                                                                                                  |  | $             | 1,997,907 |   |                   | $
|Less: current portion                                                                                  |  |               | (264,284  | ) |                   |  
|Long term portion                                                                                      |  | $             | 1,733,623 |   |                   | $



The
convertible debentures and accrued interest are convertible into shares of our common stock at the lower of $100 or the lowest
bid price for the 20 trading days prior to conversion.



As
of June 30, 2020, and December 31, 2019, we had accrued interest on the convertible debentures totaling $1,465,724 and $1,399,295,
respectively, of which $35,028 and $28,199 was current and $1,430,696 and $1,371,098 was long term, respectively. As of June 30,
2020, and December 31, 2019, the debentures, including accrued but unpaid interest, were convertible into 196,726,286 and 568,989,796
shares of our common stock.



NOTE
10—DERIVATIVE LIABILITIES



As
discussed in Note 9 - Convertible Debentures, we have entered into five separate agreements to borrow a total of $2,665,528
with the outstanding principal and interest being convertible at the holder’s option into common stock of the company at
the lesser of $100 (notes one through four) or $0.10 (note five) or the lowest closing bid price in the prior 20 trading days.
Embedded derivatives are valued separately from the host instrument and are recognized as derivative liabilities in our balance
sheet. We measure these instruments at their estimated fair value and recognize changes in their estimated fair value in results
of operations during the period of change. We have estimated the fair value of these embedded derivatives for convertible debentures
and associated warrants using a Multinomial Lattice model as of June 30, 2020, using the following assumptions:



|Volatility      |  |   | 101.5% - 129.7   | %
|--------------- |  | - | ---------------- | -
|Risk-free rates |  |   | 0.13% - 0.50     | %
|Stock price     |  | $ | 0.043            |  
|Remaining life  |  |   | 0.11- 6.83 years |  



The
fair values of the derivative instruments are measured each quarter, which resulted in a loss of $289,050 and $358,264 during
the three and six months ended June 30, 2020. As of June 30, 2020, and December 31, 2019, the fair market value of the derivatives
aggregated $1,258,096 and $894,079, respectively.



14







NOTE
11—STOCKHOLDERS’ DEFICIT



We
are authorized to issue up to 100,000,000 shares of $0.001 par value common stock. No shares were issued during the periods presented.
We had a total of 4,500,417 common shares issued and outstanding as of June 30, 2020, and December 31, 2019. During the year ended
December 31, 2019, we effected a 1:1000 reverse stock split of our outstanding stock. The impacts of the reverse stock split have
been retroactively stated.



NOTE
12—STOCK OPTIONS AND WARRANTS



Stock
Incentive Plans



During
the six months ended June 30, 2020 and 2019, we granted 8,000 and 6,000 options to purchase shares of common stock to employees.



The
8,000 options granted during the six months ended June 30, 2020, were valued using the following assumptions: estimated five-year
term, estimated volatility of 91%, and a risk-free rate of 1.61%.



During
the six months ended June 30, 2019, we granted 6,000 stock options relating to the employment agreement with Mr. Hawatmeh. The
fair market value of the options was $600, using the following assumptions: estimated seven-year term, estimated volatility of
567%, and a risk-free rate of 2.38%.



As
of June 30, 2020, and December 31, 2019, we had no unrecognized compensation related to outstanding options that have not yet
vested at year-end that would be recognized in subsequent periods. See Note 6 – Other Accrued Liabilities for a description
of amounts of option expenses included in accrued payroll and compensation expense.



During
the six months ended June 30, 2020, we issued a total of 8,000 options to purchase common stock and a total of 8,000 options expired
unexercised. As of June 30, 2020, there were 40,000 options issued and vested with a weighted average exercise price of $0.01
and a weighted average remaining life of 3.39 years.



NOTE
13—DISCONTINUED OPERATIONS



At
October 21, 2016, we exited the beverage licensing and distribution business. The assets and liabilities associated with this
business are displayed as assets and liabilities from discontinued operations as of June 30, 2020, and December 31, 2019, as a
result. Additionally, the revenues and costs associated with this business are displayed as losses from discontinued operations
for the six months ended June 30, 2020 and 2019.



Total
assets and liabilities included in discontinued operations were as follows:



|                                               |  | June 30, 2020 |            |  | December 31, 2019 |  
|---------------------------------------------- |  | ------------- | ---------- |  | ----------------- | -
|                                               |  |               |            |  |                   |  
|Assets From Discontinued Operations:           |  |               |            |  |                   |  
|Cash                                           |  | $             | -          |  |                   |  
|Total assets from discontinued operations      |  | $             | -          |  |                   | $
|                                               |  |               |            |  |                   |  
|Liabilities From Discontinued Operations:      |  |               |            |  |                   |  
|Accounts payable                               |  | $             | 19,690,380 |  |                   | $
|Accrued liabilities                            |  |               | 704,917    |  |                   |  
|Accrued interest                               |  |               | 1,098,863  |  |                   |  
|Accrued payroll and compensation expense       |  |               | 131,108    |  |                   |  
|Current maturities of long-term debt           |  |               | 239,085    |  |                   |  
|Related-party payable                          |  |               | 1,776,250  |  |                   |  
|Short-term advances payable                    |  |               | 2,784,773  |  |                   |  
|Total liabilities from discontinued operations |  | $             | 26,425,376 |  |                   | $



15







Net
loss from discontinued operations for the six months ended June 30, 2020 and 2019, were comprised of the following components:



|                                               |  | Six months ended June 30, |        
|---------------------------------------------- |  | ------------------------- | -------
|                                               |  | 2020                      |        
|                                               |  |                           |        
|Net sales                                      |  | $                         | -      
|Cost of sales                                  |  |                           | -      
|Gross profit                                   |  |                           | -      
|                                               |  |                           |        
|Operating expenses                             |  |                           |        
|Selling, general and administrative expenses   |  |                           | -      
|Total operating expenses                       |  |                           | -      
|                                               |  |                           |        
|Other income (expense)                         |  |                           |        
|Other income                                   |  |                           | -      
|Interest expense                               |  |                           | (76,523
|Total other expense                            |  |                           | (76,523
|                                               |  |                           |        
|Net income (loss) from discontinued operations |  | $                         | (76,523



NOTE
14—SUBSEQUENT EVENTS



We
have evaluated all events occurring subsequent to the financial statements and determined there are no additional items to disclose.



On
March 11, 2020, the World Health Organization characterized COVID-19 as a global pandemic. This situation is ongoing, and we are
monitoring it closely. Although our response to the COVID-19 pandemic continues to evolve, we have taken measures to mitigate
the impact on our business operations and overall financial performance. We are also constantly evaluating and responding to the
impact of the pandemic on our supply chain as compared to product demand. In addition, we actively monitor COVID-19-related developments
and may take further actions that alter our business operations as may be required by federal, state, or local authorities or
that we determine are in the best interests of our employees, customers, vendors, and stockholders. The effects of these operational
modifications will be reflected in current and future reporting periods.



16







ITEM
2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS



The
following discussion should be read in conjunction with our condensed consolidated financial statements and notes to our financial
statements included elsewhere in this report. This discussion contains forward-looking statements that involve risks and uncertainties.
Actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors
discussed elsewhere in this report.



Overview



Based
on our diversified expertise in manufacturing, marketing, distribution, and technology services in a wide variety of consumer
products, including tobacco products, medical devices, and beverages, around the world, we have an innovative and consumer-focused
approach to brand portfolio management, resting on a strong understanding of consumers domestically, and we have established a
footprint in more than 50 key, international markets.



We
devoted most of 2019 to exploring new product opportunities in a number of products. In late 2019, through our new, wholly owned
subsidiary, LBC Products, Inc., we entered into a new, five-year Exclusive Manufacturing and Distribution Agreement with GloBrands,
LLC, to manufacture, distribute, and sell condoms, electronic tobacco products, cigars, energy drinks, water beverages, and related
merchandise, all using the HUSTLER® brand name. These efforts continue. In early 2020, we completed phase one of our development
of all HUSTLER®-branded products, which enabled us to generate revenue of $528,232 and $530,314 during the three and six months
ended June 30, 2020. We expect to receive additional payments in 2020.



All
share and per-share amounts have been adjusted to give retroactive effect to a 1000-to-one reverse split of our common stock effective
September 2019.



17







Results
of Operations for the Three and Six Months Ended June 30, 2020, Compared to the Three and Six Months Ended June 30, 2019



Revenue
and Cost of Revenue



During
the three and six months ended June 30, 2020, we generated revenue of $528,232 and $530,314 and cost of revenue of $195,838 and
$197,319, respectively. All revenue generated during the periods ended June 30, 2020, was the result of activities related to
our agreement to develop and distribute certain HUSTLER® branded product. We did not generate revenue or cost of revenue during
the three months ended June 30, 2019.



Operating
Expenses



During
the three months ended June 30, 2020 and 2019, selling, general, and administrative expenses were $78,884 and $106,528, respectively,
representing a decrease of $27,644, or 25%, in the current period. During the six months ended June 30, 2020 and 2019, selling,
general, and administrative expenses were $161,544 and $181,125, respectively, representing a decrease of $19,581, or 11%, in
the current period. The decrease in selling, general, and administrative expenses during the periods ended June 30, 2020, is the
result of our recovering certain administrative salary costs through a shared services agreement that was not in place during
2019.



Other
Income and Expense



Other
income and expenses during the three months ended June 30, 2020, consisted of $156,568 in interest expense, losses on the fair
value measurement of derivative liabilities of $289,050, and other income of $2,000. Other expenses during the three months ended
June 30, 2019, included $124,771 for interest expense.



Other
income and expenses during the six months ended June 30, 2020, consisted of $312,635 in interest expense, losses on the fair value
measurement of derivative liabilities of $358,264, losses on the disposal of equipment of $9,771, and other income of $42,000.
Other expenses during the six months ended June 30, 2019, included $250,363 for interest expense and other income of $730.



Liquidity
and Capital Resources



We
have had a history of losses from operations, as our expenses have been greater than our revenue. Our accumulated deficit was
$79.0 million and $78.5 million at June 30, 2020 and December 31, 2019, respectively. As of June 30, 2020, and December 31, 2019,
we had current assets of $527,427 and $20,024, respectively, and current liabilities of $38.8 million and $38.0 million, respectively,
creating working capital deficits as of June 30, 2020, and December 31, 2019, of approximately $38.3 million and $38.0 million,
respectively.



Operating
Activities



We
have only nominal cash or short-term assets while our current liabilities aggregate $38.8 million as of June 30, 2020. During
the six months ended June 30, 2020, operations generated $205,592 of net cash, comprised of a net loss from continuing operations
of $467,219, noncash items totaling $431,049 consisting of losses recognized from the changes in fair values of derivative liabilities
and expense paid by related parties on our behalf, and changes in working capital totaling $241,762. During the six months ended
June 30, 2019, operations used $94,084 of net cash, comprised of a net loss from continuing operations of $430,758, noncash items
totaling $25,428 consisting of expenses paid by related parties on our behalf, and changes in working capital totaling $311,246.



Financing
Activities



During
the six months ended June 30, 2020, financing activities used $103,261 of cash, compared to generating $101,277 of cash during
the six months ended June 30, 2019. Cash used in financing activities during the six months ended June 30, 2020, consisted of
advances from convertible debentures totaling $15,000, repayments of bank overdrafts of $1,611, repayments on related-party payables
of $262,350, advances from related parties of $10,700, advances from loans payable of $156,000, and repayments on loans payable
$21,000. Cash provided by financing activities during the six months ended June 30, 2019, consisted of advances from convertible
notes payable of $25,000, advances from related-party loans totaling $66,277, and proceeds from loans payable of $10,000.



18







Our
Capital Resources and Anticipated Requirements



Our
monthly operating costs total approximately $25,000 per month, excluding approximately $50,000 of accruing interest expense and
capital expenditures. We continue to focus on generating revenue and reducing our monthly business expenses through cost reductions
and operational streamlining. We are sales revenue under our GloBrands agreement and expect to receive additional payments during
the balance of the year. Currently, we do not have enough cash on hand to sustain our business operations, and we expect to access
external capital resources in the near future.



In
conjunction with our efforts to commercialize new products, we are actively seeking infusions of capital from investors. In our
current financial condition, it is unlikely that we will be able to obtain additional debt financing. Even if we did acquire additional
debt, we would be required to devote additional cash flow to servicing the debt and securing the debt with assets.



Accordingly,
we are looking to obtain equity financing to meet our anticipated capital needs. We cannot assure that we will be successful in
obtaining such capital. If we were to issue additional shares for debt and/or equity, this would dilute the value of our common
stock and existing stockholders’ positions. We also have no authorized but unissued capital available, and we are dependent
on the Amendment becoming effective in order to obtain any new equity financing.



Convertible
Debentures



We
currently have an amended, restated, and consolidated secured convertible debenture with Tekfine, LLC, an unrelated entity, with
a maturity date of April 30, 2027, to the extent not previously converted. The amended debenture had a total outstanding principal
balance of $2.4 million, with accrued interest of $1.4 million as of June 30, 2020. We also have four additional convertible debentures
with Tekfine with a maturity dates between November 12, 2020, and February 8, 2021, totaling $275,000, unless earlier converted.
The convertible debentures and accrued interest are convertible into shares of our common stock at the lower of $100 or $0.10
(depending on the instrument) or the lowest bid price for the 20 trading days prior to conversion.



Going
Concern



These
interim unaudited financial statements have been prepared on the going concern basis, which assumes that adequate sources of financing
will be obtained as required and that our assets will be realized and liabilities settled in the ordinary course of business.
Accordingly, the interim unaudited financial statements do not include any adjustments related to the recoverability of assets
and classification of assets and liabilities that might be necessary should we not be unable to continue as a going concern.



Off-Balance
Sheet Arrangements



We
have no off-balance sheet arrangements.



Critical
Accounting Policies



We
have identified the policies outlined below as critical to our business operations and an understanding of our results of operations.
Refer to Note 2 – Summary of Significant Accounting Policies for discussion.



ITEM
3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK



As
a smaller reporting company, we are not required to provide the information required by this item.



19







ITEM
4. CONTROLS AND PROCEDURES



Evaluation
of Disclosure Controls and Procedures



As
of June 30, 2020, we carried out an evaluation, under the supervision and with the participation of management, including our
chief executive and financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures.
Based upon that evaluation, management concluded that our disclosure controls and procedures were not effective as of June 30,
2020, to provide reasonable assurance that the information required to be disclosed by us in reports that we file or submit under
the Exchange Act is recorded, processed, summarized, and reported within the periods prescribed by U.S. Securities and Exchange
Commission and that such information is accumulated and communicated to management, including our chief executive and financial
officer, as appropriate, to allow timely decisions regarding required disclosure.



In
designing and evaluating disclosure controls and procedures, management recognizes that any controls and procedures, no matter
how well designed and operated, can provide only reasonable, not absolute assurance of achieving the desired objectives. Also,
the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be
considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can
provide absolute assurance that all control issues and instances of fraud, if any, have been detected. These inherent limitations
include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or
mistake. The design of any system of controls is based, in part, upon certain assumptions about the likelihood of future events,
and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.



Changes
in Internal Control over Financial Reporting



There
has been no change in our internal control over financial reporting during the three months ended June 30, 2020, that has materially
affected, or is reasonably likely to materially affect, our internal control over financial reporting.



PART
II—OTHER INFORMATION



ITEM
6. EXHIBITS



The
following exhibits are filed as a part of this report:



|Exhibit
        Number* |  | Title
    of Document                                                                                                                                                         |  | Location        
|----------------------- |  | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |  | ----------------
|                        |  |                                                                                                                                                                               |  |                 
|Item
    31             |  | Rule
    13a-14(a)/15d-14(a) Certifications                                                                                                                                   |  |                 
|31.01                   |  | Certification of Principal Executive and Principal Financial Officer Pursuant to Rule 13a-14                                                                                  |  | This
    filing.
|                        |  |                                                                                                                                                                               |  |                 
|Item
    32             |  | Section
    1350 Certifications                                                                                                                                               |  |                 
|32.01                   |  | Certification of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |  | This
    filing.



|* | All
    exhibits are numbered with the number preceding the decimal indicating the applicable SEC reference number in Item 601 and
    the number following the decimal indicating the sequence of the particular document.
|- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



20







SIGNATURE
PAGE



Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.



|                           | CIRTRAN
    CORPORATION
|-------------------------- | -----------------------
|                           |                        
|Dated:
    August 19, 2020 | By:                    
|                           |                        
|                           |                        



21